Evolutionary Dynamics of Whole-Genome Influenza A/H3N2 Viruses Isolated in Myanmar from 2015 to 2019

Viruses. 2022 Oct 31;14(11):2414. doi: 10.3390/v14112414.

Abstract

This study aimed to analyze the genetic and evolutionary characteristics of the influenza A/H3N2 viruses circulating in Myanmar from 2015 to 2019. Whole genomes from 79 virus isolates were amplified using real-time polymerase chain reaction and successfully sequenced using the Illumina iSeq100 platforms. Eight individual phylogenetic trees were retrieved for each segment along with those of the World Health Organization (WHO)-recommended Southern Hemisphere vaccine strains for the respective years. Based on the WHO clades classification, the A/H3N2 strains in Myanmar from 2015 to 2019 collectively belonged to clade 3c.2. These strains were further defined based on hemagglutinin substitutions as follows: clade 3C.2a (n = 39), 3C.2a1 (n = 2), and 3C.2a1b (n = 38). Genetic analysis revealed that the Myanmar strains differed from the Southern Hemisphere vaccine strains each year, indicating that the vaccine strains did not match the circulating strains. The highest rates of nucleotide substitution were estimated for hemagglutinin (3.37 × 10-3 substitutions/site/year) and neuraminidase (2.89 × 10-3 substitutions/site/year). The lowest rate was for non-structural protein segments (4.19 × 10-5 substitutions/site/year). The substantial genetic diversity that was revealed improved phylogenetic classification. This information will be particularly relevant for improving vaccine strain selection.

Keywords: A/H3N2; evolution; genetic reassortment; mutation; next-generation sequencing; seasonal influenza; variant viruses; whole-genome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Hemagglutinin Glycoproteins, Influenza Virus / genetics
  • Hemagglutinins
  • Humans
  • Influenza A Virus, H3N2 Subtype / genetics
  • Influenza A virus* / genetics
  • Influenza Vaccines*
  • Influenza, Human* / prevention & control
  • Myanmar / epidemiology
  • Phylogeny
  • Seasons
  • Sequence Analysis, DNA

Substances

  • Hemagglutinin Glycoproteins, Influenza Virus
  • Hemagglutinins
  • Influenza Vaccines

Grants and funding

R.S. received funding from the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Japan Agency for Medical Research and Development (AMED) (15fm0108009h0001–21wm0125005h0002); Grants-in-Aid for Scientific Research (KAKENHI) by the Japan Society for the Promotion of Science (JSPS) (21K10414); Health and Labor Sciences Research Grants, Ministry of Health, Labor and Welfare, Japan (H30-Shinkougyousei-Shitei-002, H30-Shinkougyousei-Shitei-004, and 21HA2003); and Niigata Prefecture Coronavirus Infectious Disease Control Research and Human Resources Development Support Fund (grant number not available). The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or manuscript writing.